HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical implications of the interleukin 27 serum level in breast cancer.

AbstractINTRODUCTION:
Interleukin 27 (IL-27), belonging to the IL-12 family, exerts a critical role in immune regulation of infection, autoimmunity, and tumor. In this study, we aimed to investigate the roles of IL-27 and vascular endothelial growth factor (VEGF) in breast cancer.
METHODS:
The serum levels of IL-27 and VEGF in 150 patients with breast cancer and 90 control subjects were measured by an enzyme-linked immunosorbent assay. Estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 were measured by immunohistochemistry. Clinical stage, tumor size, lymph node metastasis, grade, and histological type were also recorded.
RESULTS:
The serum levels of IL-27 and VEGF were significantly greater in breast cancer patients than in the control group. In addition, there was a significant correlation between IL-27 and VEGF, and serum IL-27 and VEGF levels were associated with the clinical stage of breast cancer. Moreover, the serum levels of IL-27 were especially elevated in breast cancer patients who were estrogen receptor-positive and progesterone receptor-positive. Furthermore, the serum levels of IL-27 and VEGF decreased after patients with breast cancer had modified radical mastectomy.
CONCLUSION:
Interleukin 27 may be a new prognostic biomarker of breast cancer and a promising target to limit both angiogenesis and tumor growth.
AuthorsDapeng Lu, Xiangyu Zhou, Lutian Yao, Caigang Liu, Feng Jin, Yunfei Wu
JournalJournal of investigative medicine : the official publication of the American Federation for Clinical Research (J Investig Med) Vol. 62 Issue 3 Pg. 627-31 (Mar 2014) ISSN: 1708-8267 [Electronic] England
PMID24448601 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Estrogen Receptor alpha
  • Interleukins
  • MYDGF protein, human
  • Receptors, Progesterone
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
Topics
  • Adult
  • Biomarkers, Tumor (blood)
  • Breast Neoplasms (blood, diagnosis, surgery)
  • Estrogen Receptor alpha (blood)
  • Female
  • Humans
  • Interleukins (blood)
  • Middle Aged
  • Receptors, Progesterone (blood)
  • Vascular Endothelial Growth Factor A (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: